ONEMEDNET CORP

CEO Green Aaron’s June 2026 buy of 36,650 OneMedNet shares— a “buy‑the‑dip” move amid volatility— signals insider confidence and a potential long‑term upside despite a steep price slide.

CEO Green Aaron’s fresh OneMedNet shares signal insider confidence and AI‑driven growth, but investors should watch earnings and partnership news for a true rebound.

OneMedNet insider buying signals renewed confidence in its AI‑driven growth; CEO & CMO purchases hint at a strong future for iRWD™ platform and recurring revenue.